Blogs

In 2025, weight-loss injections such as Mounjaro and Wegovy continue to attract major attention in the UK. Clinical trials show that Mounjaro users lose an average of around 20% of…

Obesity is a growing concern, with around 1 in 4 adults in the UK now classed as obese. For many, lifestyle changes alone may not deliver the results they need,…

Travel comes with the thrill of new experiences, but it also brings real health risks. In 2025 alone, over 240,000 cases of chikungunya and 90 deaths have already been reported…

Mounjaro (tirzepatide) has quickly gained attention for its effectiveness, with clinical trials showing patients losing on average up to 21% of their body weight. With results like these, it’s no…

According to the UK Health Security Agency (UKHSA), there were 73 travel‑associated chikungunya cases reported in England between January and June 2025, compared to just 27 cases during the same…

In 2024, the UK reported more than 700 cases of typhoid and paratyphoid fever linked to international travel, marking a noticeable rise on previous years. This shows that typhoid remains…